ZOM Stock Price: Zomedica Corp extends rally following year end 2020 results

NYSEAMERICAN:ZOM gained a further 2.91% on Tuesday despite the border market retreat.
Zomedica reported its Q4 and year end 2020 earnings results on Friday after the closing bell.
Investors continue to believe that the impending Truforma release will launch Zomedica to a huge windfall.

Stocks Reporter FXStreet

NYSEAMERICAN:ZOM continued its stellar year ever since the calendar flipped to 2021, as the pet diagnostic company is still up over 500% year to date. Tuesday saw Zomedica continue its momentum from Monday as the stock gained 2.91% to close the trading session at $2.12. It has been less than a year since Zomedica was trading as a penny stock as is evident by its 52-week low price of $0.06. In the meantime, Zomedica briefly rode the wave of being a target of the Reddit sugroup r/WallStreetBets which accounted for much of the rise in the stock’s price.

Stay up to speed with hot stocks' news!

On Friday, Zomedica released its Q4 and year end 2020 financial results, and the news was somewhat optimistic for a company that has zero revenues to date. Losses were lower year-over-year from 2019, as ZOM announced losses of $16.9 million in 2020 compared to $19.8 million in 2019. This equates to roughly losses of $0.05 per share compared to $0.19 per share in 2019. Zomedic also reported it had nearly $280 million in the bank after several rounds of stock offerings to raise cash and take advantage of its current stock price.

ZOM stock forecast

Of course, the main focus for Zomedica investors continues to be the upcoming release of its Truforma pet diagnostic platform at the end of March. While a nationwide rollout does not seem to be in the cards, Zomedica is taking its time with a staggered, regional rollout, which should help keep costs lower, but at the same time, limit the rate of sales growth.

Premium

You have reached your limit of 3 free articles for this month.

Start your subscription and get access to all our original articles.

Subscribe to Premium Sign In

Author

Stocks Reporter

FXStreet

AUD/USD falls to near 0.7100 after slipping below 50-day EMA

AUD/USD depreciates after registering minor gains in the previous day, trading around 0.7120 during the Asian hours. The technical analysis of the daily chart shows the pair consolidating sideways within a rectangle pattern, as neither bulls nor bears gain control. The AUD/USD pair is holding a slight bearish tone however as it sits beneath both the nine-day and 50-day EMAs.

160.00: USD/JPY back near intervention territory after upbeat US jobs report

US Nonfarm Payrolls beat expectations by a wide margin in May, with 172K jobs added. The US Dollar rebounds after the release, helping USD/JPY recover from its intraday lows. Warnings from Japanese authorities continue to limit upside potential near the 160.00 threshold.

Gold weakens to three-month lows near $4,300

Gold faces increasing selling interest and approaches the area of three-month lows near the $4,300 mark per troy ounce on Friday. The precious metal’s decline comes as traders assess the stronger-than-expected NFP, while the bid bias in the Greenback and higher US Treasury yields also collaborate with the retracement.

Cardano hits five-year low even as Hoskinson clarifies "break" isn't an exit

Cardano (ADA) price is down 10% at press time on Friday, extending losses over 30% so far this week amid Charles Hoskinson's clarification that "break" isn't an exit.

Week ahead – Fed countdown begins amid US inflation data and geopolitical risks

Fed Chair Warsh’s first meeting approaches as key US inflation data could reshape expectations. Oil prices remain elevated as US-Iran talks continue; tariffs also return to the spotlight. ECB is expected to hike; will it be a one-off move or is July live?

The US economy defies the rules: 100 days into the Oil shock and the recession signal is still missing

More than three months after the start of the Iran war and the resulting disruption to global energy markets, the US economy continues to display remarkable resilience. The conflict has triggered a sharp rise in Oil prices, reignited inflationary pressures and fueled widespread concerns about a potential economic slowdown.